Skip to content
10-Q

Quarterly Report

Talis Biomedical Corporation

0000950170-24-098525

← back to feed
Filed
Aug 19, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 14, 2024 31.69M sh
Shares Diluted Q2 2024 · Jun 30, 2024 1.82M sh
Shares Diluted Q2 2024 · Jun 30, 2024 1.82M sh
Shares Diluted Q2 2024 · Jun 30, 2023 1.82M sh
Shares Diluted Q2 2024 · Jun 30, 2023 1.81M sh
Capex Q2 2024 · Jun 30, 2024 $0
Capex Q2 2024 · Jun 30, 2023 $509K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$17.76M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$30.74M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $59.87M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $76.73M
Cash And Equivalents Q2 2024 · Jun 30, 2023 $98.2M
Stockholders Equity Q2 2024 · Jun 30, 2024 $48.63M
Stockholders Equity Q2 2024 · Mar 31, 2024 $56.68M
Stockholders Equity Q2 2024 · Dec 31, 2023 $69.12M
Stockholders Equity Q2 2024 · Jun 30, 2023 $96.17M
Stockholders Equity Q2 2024 · Mar 31, 2023 $110.12M
Stockholders Equity Q2 2024 · Dec 31, 2022 $126.74M
Current Liabilities Q2 2024 · Jun 30, 2024 $8.2M
Current Liabilities Q2 2024 · Dec 31, 2023 $8.77M
Total Liabilities Q2 2024 · Jun 30, 2024 $24.07M
Total Liabilities Q2 2024 · Dec 31, 2023 $25.56M
Current Assets Q2 2024 · Jun 30, 2024 $63.6M
Current Assets Q2 2024 · Dec 31, 2023 $77.68M
Total Assets Q2 2024 · Jun 30, 2024 $72.7M
Total Assets Q2 2024 · Dec 31, 2023 $94.67M
Eps Diluted Q2 2024 · Jun 30, 2024 −$4.86
Eps Diluted Q2 2024 · Jun 30, 2024 −$12.01
Eps Diluted Q2 2024 · Jun 30, 2023 −$8.27
Eps Diluted Q2 2024 · Jun 30, 2023 −$18.11
Eps Basic Q2 2024 · Jun 30, 2024 −$4.86
Eps Basic Q2 2024 · Jun 30, 2024 −$12.01
Eps Basic Q2 2024 · Jun 30, 2023 −$8.27
Eps Basic Q2 2024 · Jun 30, 2023 −$18.11
Sga Expense Q2 2024 · Jun 30, 2024 $7.98M
Sga Expense Q2 2024 · Jun 30, 2024 $19.63M
Sga Expense Q2 2024 · Jun 30, 2023 $6.41M
Sga Expense Q2 2024 · Jun 30, 2023 $12.81M
Rd Expense Q2 2024 · Jun 30, 2024 $1.6M
Rd Expense Q2 2024 · Jun 30, 2024 $4.13M
Rd Expense Q2 2024 · Jun 30, 2023 $10.56M
Rd Expense Q2 2024 · Jun 30, 2023 $24.35M
Net Income Q2 2024 · Jun 30, 2024 −$8.85M
Net Income Q2 2024 · Jun 30, 2024 −$21.88M
Net Income Q2 2024 · Mar 31, 2024 −$13.04M
Net Income Q2 2024 · Jun 30, 2023 −$15.03M
Net Income Q2 2024 · Jun 30, 2023 −$32.87M
Net Income Q2 2024 · Mar 31, 2023 −$17.83M
Operating Income Q2 2024 · Jun 30, 2024 −$9.58M
Operating Income Q2 2024 · Jun 30, 2024 −$23.7M
Operating Income Q2 2024 · Jun 30, 2023 −$16.39M
Operating Income Q2 2024 · Jun 30, 2023 −$35.39M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $0
Cost Of Revenue Q2 2024 · Jun 30, 2024 $6K
Cost Of Revenue Q2 2024 · Jun 30, 2023 $7K
Cost Of Revenue Q2 2024 · Jun 30, 2023 $27K
Revenue Q2 2024 · Jun 30, 2024 $0
Revenue Q2 2024 · Jun 30, 2024 $73K
Revenue Q2 2024 · Jun 30, 2023 $581K
Revenue Q2 2024 · Jun 30, 2023 $1.8M